Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study

Neurology

Volumn 58, Issue 1, 2002, Pages 79-84

  Maher, N E ^a   Golbe, L I ^b   Lazzarini, A M ^b   Mark, M H ^b   Currie, L J ^c   Wooten, G F ^c   Saint Hilaire, M ^a   Wilk, J B ^a   Volcjak, J ^a   Maher, J E ^a   Feldman, R G ^a   Guttman, M ^d   Lew, M ^e   Schuman, S ^e   Suchowersky, O ^f   Lafontaine, A L ^f   Labelle, N ^f   Vieregge, P ^g   Pramstaller, P P ^h   Klein, C ^g   Hubble, J ⁱ   Reider, C ⁱ   Growdon, J ^j   Watts, R ^k   Montgomery, E ^l   Baker, K ^l   Singer, C ^m   Stacy, M ⁿ   Myers, R H ^a   more..

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF CALGARY   (Canada)

^g UNIVERSITY OF LÜBECK   (Germany)

^h CENTRAL HOSPITAL OF BOLZANO   (Italy)

ⁱ OHIO STATE UNIVERSITY   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l LERNER RESEARCH INSTITUTE   (United States)

^m UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁿ Barrow Clinic   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; ARTICLE; FEMALE; GENETIC PREDISPOSITION; HEAD INJURY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; SIBLING; VITAMIN INTAKE;

EID: 6444245908     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.1.79     Document Type: Article

References (54)

1. Epidemiology of Parkinson's disease
2. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan 1988-1993
3. Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London
4. Follow-up study of early life protective and risk factors in Parkinson's disease
5. Epidemiology versus genetics in Parkinson's disease: Progress in resolving an age-old debate
6. Genetic risk factors in Parkinson's disease
7. Parkinson's disease and exposure to rural environmental factors: A population based casecontrol study
8. Environmental antecedents of young-onset Parkinson's disease
9. Riskfactors for Parkinson's disease: Case control study in the province of Caceres, Spain
10. Facteurs environnementaux dans l'etiologie de la maladie de Parkinson
11. Environmental risk factors in Parkinson's disease
12. Early onset Parkinson's disease in Saskatchewan: Environmental considerations for etiology
13. Parkinson's disease and exposure to agricultural work and pesticide chemicals
14. Parkinson's disease: A test of the multifactorial etiologic hypothesis
15. Risk factors for Parkinson's disease
16. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: A case-control study in Germany
17. Prior history of head trauma in Parkinson's disease
18. The epidemiology of Parkinson's disease: A case-control study of young-onset and old-onset patients
19. Parkinson's disease mortality and the industrial use of heavy metals in Michigan
20. Do environmental toxins cause Parkinson's disease? A critical review
21. Environmental, medical and family history risk factors for Parkinson's disease: A New England-based case control study
22. Parkinson's disease: A genetic study
23. Risk of Parkinson's disease among first-degree relatives: A community-based study
24. Increased risk of Parkinson's disease in parents and siblings of patients
25. Increased risk of Parkinson's disease in relatives of patients
26. Parkinson's disease: A genetic study
27. A clinical genetic study of Parkinson's disease: Evidence for dominant transmission
28. Parkinson disease in twins: An etiologic study
29. The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins
30. Mutation in the α-synuclein gene identified in families with Parkinson's disease
31. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
32. Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in the Parkin gene in affected individuals
33. Low frequency of alpha-synuclein mutations in familial Parkinson's disease
34. Association between early-onset Parkinson's disease and mutations in the parkin gene
35. Variability and validity of polymorphism association studies in Parkinson's disease
36. Genome-wide scan for Parkinson's Disease: The GenePD Study
37. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease
38. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases
39. Clinical research criteria for the diagnosis of progressive supranuclear palsy (SteeleRichardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop
40. Coefficient of agreement for nominal scales
41. The genetic component in Parkinson's disease is half that of Alzheimer's disease
42. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family
43. Paralysis agitans: A clinical genetic study
44. Coronary risk associated with age and sex of parental heart disease in the Framingham study
45. Postmenopausal estrogen use and Parkinson's disease with and without dementia
46. Multiple antioxidants in the prevention and treatment of Parkinson's disease
47. Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease
48. Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease
49. Dietary factors in Parkinson's disease: The role of food groups and specific foods
50. Smoking and Parkinson's disease: A dose-response relationship
51. Nicotinic receptors and Parkinson's disease
52. Nicotinic system involvement in Alzheimer's and Parkinson's diseases: Implications for therapeutics